Skip to main content

Table 2 The In-hospital outcomes

From: Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study

 

All

(n = 232)

SGLT-2i group

(n = 128)

non-SGLT-2i group

(n = 104)

P value

Hospital stay, days

8 (6–10)

8 (6–10)

8 (6–12)

0.654

High risk of death after discharge

57 (24.6%)

33 (25.8%)

24 (23.1%)

0.634

Acute heart failure

64 (27.7%)

37 (28.9%)

27 (26.0%)

0.618

New-onset cardiac arrhythmias

30 (13.1%)

14 (10.9%)

16 (15.8%)

0.621

Hypotensive events

25 (10.8%)

15 (11.7%)

10 (9.6%)

0.607